Angiotensin II-mediated activation of fibrotic pathways through ERK1/2 in rat peritoneal mesothelial cells

REFERENCES

• Nakamoto H, Kawaguchi Y, Suzuki H. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv Perit Dial. 2002;18:119–123.
   PubMedGoogle Scholar
• Shostak A, Pivnik K, Gotloib L. Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state. Nephrol Dial Transplant. 1996;11:608–613.
   PubMed Web of Science ®Google Scholar
• Stojimirovic B, Trpinac D, Obradovic M, Milutinovic D, Obradovic D, Nesic V. Changes in peritoneal mesothelial cells in patients on peritoneal dialysis. Med Pregl. 2001;54:219–223.
   PubMedGoogle Scholar
• Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int. 2002;22:171–177.
   PubMed Web of Science ®Google Scholar
• Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int. 1992;12:14–27.
   PubMed Web of Science ®Google Scholar
• Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol. 2001;12:2029–2039.
   PubMed Web of Science ®Google Scholar
• Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol. 1993;3:1531–1540.
   PubMed Web of Science ®Google Scholar
• Brown NJ, Vaughan DE, Fogo AB. The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease. Semin Nephrol. 2002;22:399–406.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep. 2003;5:73–79.
   PubMed Web of Science ®Google Scholar
• Duman S, Sen S, Duman C, Oreopoulos DG. Effect of valsartan versus lisinopril on peritoneal sclerosis in rats. Int J Artif Organs. 2005;28:156–163.
   PubMed Web of Science ®Google Scholar
• Yao Q, Ayala ER, Qian JQ, Stenvinkel P, Axelsson J, Lindholm B. A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells. Clin Nephrol. 2007;68:295–301.
   PubMed Web of Science ®Google Scholar
• Ersoy R, Celik A, Yilmaz O, The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats. Perit Dial Int. 2007;27:424–431.
   PubMed Web of Science ®Google Scholar
• Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 1990;37:1563–1570.
   PubMed Web of Science ®Google Scholar
• Thellin O, Zorzi W, Lakaye B, Housekeeping genes as internal standards: Use and limits. J Biotechnol. 1999;75:291–295.
   PubMed Web of Science ®Google Scholar
• Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: Analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 2005;21:389–395.
   PubMed Web of Science ®Google Scholar
• Kiribayashi K, Masaki T, Naito T, Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int. 2005;67:1126–1135.
   PubMed Web of Science ®Google Scholar
• Noh H, Ha H, Yu MR, Kim YO, Kim JH, Lee HB. Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int. 2005;25:38–47.
   PubMed Web of Science ®Google Scholar
• Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension. 2001;38:635–638.
   PubMed Web of Science ®Google Scholar
• Kyuden Y, Ito T, Masaki T, Yorioka N, Kohno N. TGF-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells. Perit Dial Int. 2005;25:483–491.
   PubMed Web of Science ®Google Scholar
• White ES, Baralle FE, Muro AF. New insights into form and function of fibronectin splice variants. J Pathol. 2008;216:1–14.
   PubMed Web of Science ®Google Scholar
• Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: Fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008;20:495–501.
   PubMed Web of Science ®Google Scholar
• Huang Y, Noble NA. PAI-1 as a target in kidney disease. Curr Drug Targets. 2007;8:1007–1015.
   PubMed Web of Science ®Google Scholar
• Wang JC. Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia. Leuk Lymphoma. 2005;46:1261–1268.
   PubMed Web of Science ®Google Scholar
• Martin J, Yung S, Robson RL, Steadman R, Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int. 2000;20:524–533.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res. 2002;35:1001–1015.
   PubMed Web of Science ®Google Scholar
• Guo DF, Sun YL, Hamet P, Inagami T. The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res. 2001;11:165–180.
   PubMed Web of Science ®Google Scholar
• Sitter T, Haslinger B, Mandl S, Fricke H, Held E, Sellmayer A. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity. J Am Soc Nephrol. 1998;9:2005–2012.
   PubMed Web of Science ®Google Scholar
• Xu ZG, Kim KS, Park HC, High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Kidney Int. 2003;63:958–968.
   PubMed Web of Science ®Google Scholar
• Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem. 2003;278:26793–26802.
   PubMed Web of Science ®Google Scholar
• Perlman A, Lawsin LM, Kolachana P, Saji M, Moore J Jr., Ringel MD. Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and map kinase. Ann Clin Lab Sci. 2004;34:277–286.
   PubMed Web of Science ®Google Scholar
• Liu B, Yu J, Taylor L, Zhou X, Polgar P. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in rat1 fibroblasts. J Cell Biochem. 2006;97:1104–1120.
   PubMed Web of Science ®Google Scholar
• Cano E, Mahadevan LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci. 1995;20:117–122.
   PubMed Web of Science ®Google Scholar
• Fischer JW, Stoll M, Hahn AW, Unger T. Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells. Cardiovasc Res. 2001;51:784–791.
   PubMed Web of Science ®Google Scholar
• Uchiyama-Tanaka Y, Matsubara H, Nozawa Y, Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int. 2001;60:2153–2163.
   PubMed Web of Science ®Google Scholar